Key result
Targeted overexpression of the human beta2-adrenergic receptor in transgenic mice markedly enhanced myocardial relaxation, shortening the time constant of isovolumic pressure decline by 43%, and reduced phospholamban protein levels by 44%.
Why the study?
Does targeted myocardial overexpression of the human beta2-AR gene alter myocardial relaxation and phospholamban regulation in transgenic mice?
Population
Transgenic mice overexpressing the human beta2-adrenergic receptor gene and negative littermate controls.
Comparison
Targeted myocardial overexpression of the human… vs Negative littermate controls.
Design
Preclinical
Authors
Loading...
Hypothesis-generating for beta2-AR modulation in diastolic function; human validation required before clinical consideration.
Does targeted myocardial overexpression of the human beta2-AR gene alter myocardial relaxation and phospholamban regulation in transgenic mice?
Absolute Event Rate: 7.8% vs 13.6%
p-value: p=<0.001
Chronic beta2-adrenergic receptor stimulation in vivo leads to enhanced, maximal myocardial relaxation and a selective reduction in phospholamban protein.
Rockman et al. (1996) studied Myocardial relaxation (n=17). Overexpression of human beta2-adrenergic receptor vs. Negative littermate controls was evaluated on Time constant of left ventricular isovolumic pressure decline (Tau) at baseline in milliseconds (p=<0.001). Targeted overexpression of the human beta2-adrenergic receptor in transgenic mice markedly enhanced myocardial relaxation, shortening the time constant of isovolumic pressure decline by 43%, and reduced phospholamban protein levels by 44%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: